ESE. V. Sandalkin

E. V. Sandalkin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


E. V. Sandalkin has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study of the effectiveness of nitric oxide use during and after heart valve surgery with cardiopulmonary bypass

    by V. V. Pichugin, A. V. Deryugina, V. D. Selemir, A. V. Bogush, R. D. Trofimov, A. S. Starshov, E. V. Sandalkin, I. A. Pakhomov, S. A. Zhilyaev, E. V. Knyazeva, et al.

    Aim. To assess the effect of nitric oxide administered into the extracorporeal circuit and during the three-day postoperative period on oxidative stress parameters and the state of red blood cells during operations with cardiopulmonary bypass (CPB).Material and Methods. The study included 106 patients who underwent heart valve surgeries and combined interventions under CPB. Two groups of patients were created: control (53 patients); study (53 patients). Nitric oxide (40 ppm) was supplied to the oxygenator of the CPB machine and by inhalation for three days after surgery. At the stages and after the surgery, the concentration of diene (DC) and triene (TC) conjugates, Schiff bases (SB); erythrocyte catalase activity (CA) was studied; aggregation and electrophoretic mobility of erythrocytes were measured. Clinical outcomes of surgeries were studied.Results. In patients of the control group, statistically significant increase in the content of DC (by 1.2 times) and SB (by 2.0 times) was registered by the end of the surgery compared to the initial values. SB content did not return to the preoperative level even by the end of the third day after the operation. A sharp decrease in CA activity by the end of the operation (by 24.1%) and its further decrease during three postoperative days were marked. A statistically significant increase in erythrocyte aggregation was established, starting from 60 min of CB (by 18.0% higher than the initial one), reaching a maximum by the end of the operation (by 20.4% higher than the initial one) and remaining above the initial level throughout the postoperative period. The use of nitric oxide during and after the surgery made it possible to statistically significantly decrease the level of DC, TC, SB; increase the activity of erythrocyte catalase; reduce erythrocyte aggregation and increase their electrophoretic mobility both during CBP and in the postoperative period.Conclusion. Cardiopulmonary bypass stimulates the development of lipid peroxidation (LPO) processes and erythrocyte damage, which occur during surgery and continue in the immediate postoperative period. Nitric oxide, used both during cardiopulmonary bypass and during the three-day postoperative period, effectively prevents the activation of LPO processes, has an antioxidant effect, reduces erythrocyte aggregation and increases their electrophoretic mobility. The positive effect of nitric oxide is noted not only during cardiopulmonary bypass, but also during the postoperative period, which improves the clinical outcomes of heart surgery.


  • Open Access

    Delivery of Gaseous Nitric Oxide to the Extracorporeal Circulation Circuit: Experimental and Clinical Data: a review

    by Vladimir V. Pichugin, A. E. Bautin, S. E. Domnin, M. V. Ryazanov, E. V. Sandalkin

    Introduction. Usually, gaseous nitric oxide (NO) is supplied to the patient by inhalation, adding to the inhaled gas mixture during spontaneous breathing, or supplying it to the inspiratory part of the ventilator. It is believed that the main point of its action is the pulmonary vasculature, where it exhibits an expanding effect, thus improving the oxygenation of arterial blood and reducing the pulmonary artery pressure. However, data from recent experimental clinical studies suggest that the addition of NO directly to the gas mixture supplied to the oxygenator makes it possible to systemically deliver NO into the bloodstream and, thereby, reduce the inflammatory response of the whole body caused by the extracorporeal circuit (cardiopulmonary bypass [CPB] or extracorporeal membrane oxygenation [ECMO]). Materials and methods. The search for publications was carried out in electronic databases PubMed, EMBASE. The last search term was December 30, 2020. The search term included the following words: “nitric oxide” and “artificial circulation” or “ECMO”. Only experimental and clinical randomized controlled blinded studies were selected for inclusion in the review. Results. The article analyzes data from recent studies related to the delivery of gaseous NO to the extracorporeal circuit, among which the issues of both NO delivery into the cardiopulmonary bypass line and the systemic and organ effects of nitric oxide delivered to the circuit are considered. The cardioprotective and anti-inflammatory effects of NO supplied to the extracorporeal circulation are considered in detail, as well as its effect on the lungs and kidneys. Conclusions. Further new randomized trials are needed to determine the place of the technology for supplying gaseous nitric oxide to the line of heart-lung machines or ECMO in modern cardiac surgery.